Neither peptide is FDA-approved for human therapeutic use
The nuclear factor erythroid 2-related factor 2 ( NFE2L2 or NRF2) transcription factor is constitutively activated in many cancers and promotes a specific gene expression program involved in cellular detoxification, redox buffering, and metabolic rewiring (Cancer Genome Atlas Research, 2012
More noticeable effects, particularly around recovery and mobility, tend to appear after 3 to 4 weeks
In addition, the concentration of cyanocobalamin is detectable in plasma only in smokers due to the increased cyanide exposure of cigarette smoke in combination with the dietary supplement (Domke et al., 2004)
Sharma K C, Wang J, Jiang Z, et al